189 related articles for article (PubMed ID: 15526374)
1. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
Xu X; Li J; Wu J; Zhu R; Ji W
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):206-217. PubMed ID: 29075881
[TBL] [Abstract][Full Text] [Related]
4. The use of ¹²⁵I seed strands for intraluminal brachytherapy of malignant obstructive jaundice.
Chen Y; Wang XL; Yan ZP; Wang JH; Cheng JM; Gong GQ; Luo JJ
Cancer Biother Radiopharm; 2012 Jun; 27(5):317-23. PubMed ID: 21902546
[TBL] [Abstract][Full Text] [Related]
5. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N
Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567
[TBL] [Abstract][Full Text] [Related]
6. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
7. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
8. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
9. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
11. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of self-expandable metallic stent combined with
Sheng Y; Fu X; Wang G; Mu M; Jiang W; Chen Z; Qi H; Gao F
Cancer Imaging; 2023 Apr; 23(1):33. PubMed ID: 37016400
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal brachytherapy in bile duct carcinomas.
Leung J; Guiney M; Das R
Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of biliary stenting alone versus stenting combined with iodine-125 seed strand implantation for the treatment of cholangiocarcinoma with malignant obstructive jaundice: a prospective, nonrandomized, controlled clinical study.
Luo J; Shao GL; Yao HX; Zheng JP; Zhang ZW; Cao F; Qian CY
Ann Palliat Med; 2022 Jul; 11(7):2422-2431. PubMed ID: 35927776
[TBL] [Abstract][Full Text] [Related]
15. Malignant obstructive jaundice treated with intraluminal placement of Iodine-125 seed strands and metal stents: An analysis of long-term outcomes and prognostic features.
Ma J; Luo J; Gu J; Liu Q; Liu L; Zhang W; Zhang Z; Yan Z
Brachytherapy; 2018; 17(4):689-695. PubMed ID: 29748084
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intraluminal brachytherapy combined with and without stent placement for treatment of obstructive jaundice induced by tumor thrombus.
Sun H; Yang M; Wang F; Zhao D; Qu X; Yan Z; Li F; Liu L
Brachytherapy; 2023; 22(6):833-839. PubMed ID: 37734995
[TBL] [Abstract][Full Text] [Related]
17. Preliminary application of brachytherapy with double-strand
Li ZM; Jiao DC; Han XW; Lei QY; Zhou XL; Xu M
Surg Endosc; 2022 Jul; 36(7):4932-4938. PubMed ID: 34845555
[TBL] [Abstract][Full Text] [Related]
18. Clinical Study on Using
Wang T; Liu S; Zheng YB; Song XP; Sun BL; Jiang WJ; Wang LG
Anticancer Res; 2017 Aug; 37(8):4649-4653. PubMed ID: 28739766
[No Abstract] [Full Text] [Related]
19. Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice.
Pan H; Liang Z; Yin TS; Xie Y; Li DW
Med Oncol; 2014 Mar; 31(3):853. PubMed ID: 24464214
[TBL] [Abstract][Full Text] [Related]
20. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
